Study finds tapering TNF inhibitors increases flares, lowers Boolean remission rates for RA patients in remission

New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, has found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had significantly more flares and lower Boolean 2.0 remission rates compared with those who continued treatment…
Read More

About The Author

Jonathan Jeriah

See author's posts